Indian shares edge higher; TCS gains on hopes of share buyback

Published 13-06-2018, 11:47 am
© Reuters.  Indian shares edge higher; TCS gains on hopes of share buyback
NSEI
-
NIPHARM
-
BRTI
-
VODA
-
KECL
-
RELI
-
SUN
-
TCS
-
BSESN
-

* NSE index up 0.29 pct, BSE index 0.34 pct higher

* Strong April industrial output boosts sentiment

* TCS gains on hopes of share buyback

By Jessica Kuruthukulangara

June 13 (Reuters) - Indian shares edged higher or Wednesday, set for their third straight winning session, as top software services exporter Tata Consultancy Services Ltd TCS.NS gained on hopes that it would buy back stock, while solid monthly industrial growth data on Tuesday boosted market sentiment.

Industrial output INIP=ECI grew 4.9 percent in April from a year earlier, driven by a pick up in manufacturing, while annual retail inflation accelerated to a four-month high in May, driven by higher fuel prices and a depreciating rupee, government data showed on Tuesday. is still an undercurrent of optimism. Impact of inflation may not be so much but industrial output figures were decent, which is supportive for the markets," said Jayant Manglik, president, Religare Broking.

Globally, investors are waiting for the U.S. Federal Reserve's policy decision later in the day and any clues it might give on future rate increases that could alter the course of global economic growth and corporate earnings. MKTS/GLOB

"We'll have to wait for the Fed decision to be announced and then perhaps we'll see some action," Manglik added.

The broader NSE index .NSEI was up 0.29 percent at 10,874.20 as of 0611 GMT, while the benchmark BSE index .BSESN was 0.34 percent higher at 35,813.55.

Tata Consultancy Services rose as much as 2.3 percent after the company said it would consider a share buyback proposal on Friday. of Sun Pharmaceutical Industries SUN.NS gained as much as 3.8 percent after the drugmaker said on Tuesday that supply restrictions imposed on its Halol plant by the U.S. Food and Drug Administration have been lifted. Nifty pharma index .NIPHARM continued its gaining run, rising as much as 2.4 percent and was set to post its sixth session of gains.

KEC International Ltd KECL.NS climbed as much as 3.9 percent after brokerage Macquarie Research initiated coverage on the stock with "outperform" rating. Bharti Airtel Ltd BRTI.NS dropped as much as 1.9 percent and Idea Cellular Ltd IDEA.NS fell over 5 percent after rival Reliance Jio, the telecoms arm of Reliance Industries Ltd RELI.NS , responded to Airtel's latest plan by offering more data to users.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.